No. Salvia Divinorum is not explicitly banned in Switzerland, but its psychoactive constituent, salvinorin A, falls under the 2026 Narcotics Act amendments, classifying it as a controlled substance. Possession, sale, or cultivation without authorization risks criminal liability under federal drug laws.
Key Regulations for Salvia Divinorum in Switzerland
- Federal Narcotics List Compliance: Salvinorin A is listed in Annex 1 of the 2026 Narcotics Act revisions, prohibiting non-medical use.
- Cantonal Enforcement: Local authorities (e.g., Kantonspolizei Zürich, Genève Police) enforce restrictions via drug law ordinances, with penalties including fines or imprisonment.
- Import/Export Bans: The Federal Office of Public Health (FOPH) requires special permits for research or therapeutic use; unauthorized cross-border transport violates the Schweizerische Betäubungsmittelgesetz (BetmG).
Swiss courts have upheld prosecutions under analog provisions for structurally similar compounds, reinforcing judicial scrutiny of Salvia Divinorum. The Schweizerische Eidgenossenschaft aligns enforcement with EU precursor regulations, though no THC-like decriminalization applies.